𝔖 Bobbio Scriptorium
✦   LIBER   ✦

362 Targeting the glycolytic cancer cell – cancer-specific modulation of NAD+ and NADH and implications for anti-cancer therapy

✍ Scribed by S.J. Allison; J.R.P. Knight; J. Milner; R.M. Phillips

Book ID
119602143
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
48 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ErbB4 increases the proliferation potent
ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy
✍ Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB 👁 1 views

## Abstract Clinical and experimental data suggest that ErbB‐4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbB‐4 receptor is correlated with